Literature DB >> 28836302

Combination of cuprizone and experimental autoimmune encephalomyelitis to study inflammatory brain lesion formation and progression.

Bernhard Josef Rüther1, Miriam Scheld1, Daniela Dreymueller2, Tim Clarner1, Eugenia Kress3, Lars-Ove Brandenburg3, Tine Swartenbroekx4, Chloé Hoornaert4, Peter Ponsaerts4, Petra Fallier-Becker5, Cordian Beyer1, Sven Olaf Rohr6, Christoph Schmitz6, Uta Chrzanowski6, Tanja Hochstrasser6, Stella Nyamoya1,6, Markus Kipp6.   

Abstract

Brain-intrinsic degenerative cascades are a proposed factor driving inflammatory lesion formation in multiple sclerosis (MS) patients. We recently described a model combining noninflammatory cytodegeneration (via cuprizone) with the classic active experimental autoimmune encephalomyelitis (Cup/EAE model), which exhibits inflammatory forebrain lesions. Here, we describe the histopathological characteristics and progression of these Cup/EAE lesions. We show that inflammatory lesions develop at various topographical sites in the forebrain, including white matter tracts and cortical and subcortical grey matter areas. The lesions are characterized by focal demyelination, discontinuation of the perivascular glia limitans, focal axonal damage, and neutrophil granulocyte extravasation. Transgenic mice with enhanced green fluorescent protein-expressing microglia and red fluorescent protein-expressing monocytes reveal that both myeloid cell populations contribute to forebrain inflammatory infiltrates. EAE-triggered inflammatory cerebellar lesions were augmented in mice pre-intoxicated with cuprizone. Gene expression studies suggest roles of the chemokines Cxcl10, Ccl2, and Ccl3 in inflammatory lesion formation. Finally, follow-up experiments in Cup/EAE mice with chronic disease revealed that forebrain, but not spinal cord, lesions undergo spontaneous reorganization and repair. This study underpins the significance of brain-intrinsic degenerative cascades for immune cell recruitment and, in consequence, MS lesion formation.
© 2017 Wiley Periodicals, Inc.

Entities:  

Keywords:  EAE; cuprizone; inflammation; multiple sclerosis

Mesh:

Substances:

Year:  2017        PMID: 28836302     DOI: 10.1002/glia.23202

Source DB:  PubMed          Journal:  Glia        ISSN: 0894-1491            Impact factor:   7.452


  22 in total

Review 1.  Remyelination Pharmacotherapy Investigations Highlight Diverse Mechanisms Underlying Multiple Sclerosis Progression.

Authors:  George S Melchor; Tahiyana Khan; Joan F Reger; Jeffrey K Huang
Journal:  ACS Pharmacol Transl Sci       Date:  2019-11-14

2.  Toll-Like Receptor 2-Mediated Glial Cell Activation in a Mouse Model of Cuprizone-Induced Demyelination.

Authors:  Stefan Esser; Larissa Göpfrich; Kai Bihler; Eugenia Kress; Stella Nyamoya; Simone C Tauber; Tim Clarner; Matthias B Stope; Thomas Pufe; Markus Kipp; Lars-Ove Brandenburg
Journal:  Mol Neurobiol       Date:  2017-12-29       Impact factor: 5.590

3.  Siponimod ameliorates metabolic oligodendrocyte injury via the sphingosine-1 phosphate receptor 5.

Authors:  Newshan Behrangi; Leo Heinig; Linda Frintrop; Emily Santrau; Jens Kurth; Bernd Krause; Dimitrinka Atanasova; Tim Clarner; Athanassios Fragoulis; Markus Joksch; Henrik Rudolf; Sven G Meuth; Sarah Joost; Markus Kipp
Journal:  Proc Natl Acad Sci U S A       Date:  2022-09-26       Impact factor: 12.779

Review 4.  Current advancements in promoting remyelination in multiple sclerosis.

Authors:  David Kremer; Rainer Akkermann; Patrick Küry; Ranjan Dutta
Journal:  Mult Scler       Date:  2018-10-01       Impact factor: 6.312

5.  Differential Expression of Klotho in the Brain and Spinal Cord is Associated with Total Antioxidant Capacity in Mice with Experimental Autoimmune Encephalomyelitis.

Authors:  Mohammad Sajad Emami Aleagha; Mohammad Hossein Harirchian; Shahram Lavasani; Mohammad Javan; Abdolamir Allameh
Journal:  J Mol Neurosci       Date:  2018-03-14       Impact factor: 3.444

6.  Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration.

Authors:  Lynn van Olst; Carla Rodriguez-Mogeda; Carmen Picon; Svenja Kiljan; Rachel E James; Alwin Kamermans; Susanne M A van der Pol; Lydian Knoop; Iliana Michailidou; Evelien Drost; Marc Franssen; Geert J Schenk; Jeroen J G Geurts; Sandra Amor; Nicholas D Mazarakis; Jack van Horssen; Helga E de Vries; Richard Reynolds; Maarten E Witte
Journal:  Acta Neuropathol       Date:  2021-03-29       Impact factor: 17.088

7.  Brain region-specific enhancement of remyelination and prevention of demyelination by the CSF1R kinase inhibitor BLZ945.

Authors:  Nicolau Beckmann; Elisa Giorgetti; Anna Neuhaus; Stefan Zurbruegg; Nathalie Accart; Paul Smith; Julien Perdoux; Ludovic Perrot; Mark Nash; Sandrine Desrayaud; Peter Wipfli; Wilfried Frieauff; Derya R Shimshek
Journal:  Acta Neuropathol Commun       Date:  2018-02-15       Impact factor: 7.801

8.  miRNA profile is altered in a modified EAE mouse model of multiple sclerosis featuring cortical lesions.

Authors:  Nicola S Orefice; Owein Guillemot-Legris; Mireille Alhouayek; Giulio G Muccioli; Rosanna Capasso; Pauline Bottemanne; Philippe Hantraye; Michele Caraglia; Giuseppe Orefice
Journal:  Elife       Date:  2020-09-17       Impact factor: 8.140

Review 9.  Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action.

Authors:  Newshan Behrangi; Felix Fischbach; Markus Kipp
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

Review 10.  The Cuprizone Model: Dos and Do Nots.

Authors:  Jiangshan Zhan; Teresa Mann; Sarah Joost; Newshan Behrangi; Marcus Frank; Markus Kipp
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.